Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds RBC Capital Maintains Outperform on Masonite International, Raises Price Target to $99

RBC Capital Maintains Outperform on Masonite International, Raises Price Target to $99

RBC Capital analyst Mike Dahl maintains Masonite International (NYSE:DOOR) with a Outperform and raises the price target from $90 to $99.

byBenzinga Newsdesk

August 10, 2022

1 minute read

RBC Capital analyst Mike Dahl maintains Masonite International (NYSE:DOOR) with a Outperform and raises the price target from $90 to $99.

Apple Watch Now Directly Syncs With Dexcom’s G7 Glucose Monitor

By Ananya Gairola

June 9, 11:07 PM

Dexcom Inc. has enabled direct Apple Watch connectivity for its G7 glucose monitor, allowing users to access real-time glucose data without needing an iPhone.

AAPL

Psychedelic Therapeutics For Human Stroke: Participant Screening Expects To Begin Soon

By Lara Goldstein

November 16, 1:47 PM

Canadian clinical-stage psychedelics company Algernon Pharmaceuticals Inc.

AGNPF

Citigroup Maintains Neutral on Hess, Raises Price Target to $160

By Benzinga Newsdesk

January 27, 12:50 PM

Citigroup analyst Scott Gruber maintains Hess (NYSE:HES) with a Neutral and raises the price target from $155 to $160.

HES

Analyst Ratings

Analyst Expectations for Sunnova Energy Intl’s Future

By Benzinga Insights

December 8, 10:00 AM

Over the past 3 months, 19 analysts have published their opinion on Sunnova Energy Intl (NYSE:NOVA) stock. These…

NOVA

RBC Capital Maintains Outperform on Masonite International, Raises Price Target to $99

Related Posts

Apple Watch Now Directly Syncs With Dexcom’s G7 Glucose Monitor

Psychedelic Therapeutics For Human Stroke: Participant Screening Expects To Begin Soon

Citigroup Maintains Neutral on Hess, Raises Price Target to $160

Analyst Expectations for Sunnova Energy Intl’s Future